GST 2.0 Refrom: 36 essential Medicines To Become Tax Free Starting Monday- Full List Inside

India’s Central Government, following the 56th GST Council meeting held on September 3, 2025, has announced a major overhaul of the country’s indirect tax system. In a bid to simplify taxation and improve transparency, the government is transitioning to a streamlined two-tier GST structure.

Under the revised system, goods and services across the country will now fall under either the 5% or 18% GST bracket, replacing the earlier four-slab structure of 5%, 12%, 18%, and 28%. This shift aims to make compliance easier and pricing more consistent. Additionally, in a significant move aimed at enhancing access to critical healthcare, the government has completely exempted a number of life-saving medicines from GST.

Life-Saving Medicines to Get Cheaper from Monday

Starting Monday, September 22, 2025, 36 essential life-saving medicines and drugs will become more affordable, as the government has decided to waive the existing 5% GST on most of them. This move is expected to make critical treatments more accessible to the public and encourage wider availability of essential drugs across the nation.

Here’s a paraphrased list of all the medicines mentioned in your passage, grouped by their GST changes:

Medicines Now at Zero GST (Previously 12%):

1. Agalsidase Beta
2. Imiglucerase
3. Eptacog alfa activated recombinant coagulation factor VIIa
4. Onasemnogene abeparvovec
5. Asciminib
6. Mepolizumab
7. Pegylated Liposomal Irinotecan
8. Daratumumab
9. Daratumumab subcutaneous
10. Teclistamab
11. Amivantamab
12. Alectinib
13. Risdiplam
14. Obinutuzumab
15. Polatuzumab vedotin
16. Entrectinib
17. Atezolizumab
18. Spesolimab
19. Velaglucerase Alpha
20. Agalsidase Alfa
21. Rurioctocog Alpha Pegol
22. Idursulphatase
23. Alglucosidase Alfa
24. Laronidase
25. Olipudase Alfa
26. Tepotinib
27. Avelumab
28. Emicizumab
29. Belumosudil
30. Miglustat
31. Velmanase Alfa
32. Alirocumab
33. Evolocumab
34. Cystamine Bitartrate
35. CI-Inhibitor injection
36. Inclisiran

Medicines Now at Reduced GST of 5% (Previously 12%):

• All drugs and medicines containing:
  • Fluticasone Furoate + Umeclidinium + Vilanterol (FF/UMEC/VI)
  • Brentuximab Vedotin
  • Ocrelizumab
  • Pertuzumab
  • Pertuzumab + Trastuzumab
  • Faricimab

Here’s a paraphrased list of all the medicines mentioned in your passage, grouped by their GST changes:

Medicines Now at Zero GST (Previously 12%):

1. Agalsidase Beta
2. Imiglucerase
3. Eptacog alfa activated recombinant coagulation factor VIIa
4. Onasemnogene abeparvovec
5. Asciminib
6. Mepolizumab
7. Pegylated Liposomal Irinotecan
8. Daratumumab
9. Daratumumab subcutaneous
10. Teclistamab
11. Amivantamab
12. Alectinib
13. Risdiplam
14. Obinutuzumab
15. Polatuzumab vedotin
16. Entrectinib
17. Atezolizumab
18. Spesolimab
19. Velaglucerase Alpha
20. Agalsidase Alfa
21. Rurioctocog Alpha Pegol
22. Idursulphatase
23. Alglucosidase Alfa
24. Laronidase
25. Olipudase Alfa
26. Tepotinib
27. Avelumab
28. Emicizumab
29. Belumosudil
30. Miglustat
31. Velmanase Alfa
32. Alirocumab
33. Evolocumab
34. Cystamine Bitartrate
35. CI-Inhibitor injection
36. Inclisiran

Medicines Now at Reduced GST of 5% (Previously 12%):

• All drugs and medicines containing:
  • Fluticasone Furoate + Umeclidinium + Vilanterol (FF/UMEC/VI)
  • Brentuximab Vedotin
  • Ocrelizumab
  • Pertuzumab
  • Pertuzumab + Trastuzumab
  • Faricimab

Also Read: NextGen GST 2.0 vs Original GST: Key Changes, Simplified Slabs, and What It Means for Businesses and Consumers